We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ORIS:NASDAQOriental Rise Holdings Limited Analysis

Data as of 2026-06-21 - not real-time

$0.51

Latest Price

8/10Risk

Risk Level: High

Executive Summary

The stock is trading well below its short‑term and mid‑term moving averages, indicating a pronounced lag behind recent price trends. The long‑term average sits far above the current price, underscoring a bearish gap. RSI hovers around the neutral midpoint, suggesting neither strong overbought nor oversold pressure. MACD has turned bullish, with the line just above its signal, offering a modest technical upside. The identified support level lies near a price far above today’s trading level, while resistance sits at a substantially higher ceiling, limiting near‑term upside. Volatility is exceptionally high, reflecting wild price swings that amplify risk.
Beta below one indicates the stock moves less than the broader market, yet the extreme greed sentiment may attract speculative buying. Valuation multiples are at the extreme low end, with price‑to‑earnings and price‑to‑book both near zero, making the stock appear deeply discounted. However, profitability metrics are weak: operating margins are negative, cash flow is negative, and free cash flow is deeply in the red. The balance sheet is relatively clean with modest debt, but the massive drawdown from historical highs highlights severe price erosion. The company operates in the Chinese packaged‑food sector, exposing it to regulatory and geographic headwinds that can affect earnings stability. Given the blend of technical modest bullish signals, severe valuation compression, and fragile fundamentals, the outlook favors caution with a bias toward waiting for clearer recovery signs.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • price far below moving averages
  • weak cash flow
  • high volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • technical bullish MACD
  • deep valuation discount
  • ongoing earnings weakness

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • potential turnaround in Chinese consumer demand
  • clean balance sheet
  • extreme valuation floor

Key Metrics & Analysis

Financial Health

Revenue Growth-1.30%
Profit Margin5.57%
P/E Ratio0.4
ROE0.92%
ROA-0.74%
Debt/Equity0.42
P/B Ratio0.0
Op. Cash Flow$-583000
Free Cash Flow$-2323125

Technical Analysis

TrendNeutral
RSI47.3
Support$1.31
Resistance$2.88
MA 20$2.13
MA 50$2.03
MA 200$6.62
MACDBullish
VolumeDecreasing
Fear & Greed Index91.46

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta0.88
Volatility140.27%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.